Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Research And Development Expense of $4.98 million for the year ending 2025.
- NEUROONE MEDICAL TECHNOLOGIES Corp showed a decrease of -1.6% in Research And Development Expense from 2024 to 2025.
- This data is from NEUROONE MEDICAL TECHNOLOGIES Corp's annual report (Form 10-K), filed with the SEC on December 17, 2025.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), NEUROONE MEDICAL TECHNOLOGIES Corp's Research And Development Expense has grown by 225.9%.
- Historical annual values: Fiscal year 2025: $4.98 million | Fiscal year 2024: $5.07 million | Fiscal year 2023: $6.94 million | Fiscal year 2022: $4.93 million | Fiscal year 2021: $3.93 million | Fiscal year 2020: $2.08 million | Fiscal year 2019: $1.53 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: